Market News

Latest financial and economic news and analysis

Zacks Investment Research News Agency
4 days ago•Zacks Investment Research
Stocks Medium Importance Neutral
Brilliant Earth Group, Inc. (BRLT) Q2 Earnings and Revenues Surpass Estimates

Brilliant Earth Group, Inc. (BRLT) Q2 Earnings and Revenues Surpass Estimates

Brilliant Earth Group, Inc. (BRLT) came out with quarterly earnings of $0.03 per share, beating the Zacks Consensus Estimate of a loss of $0.01 per share. This compares to earnings of $0.01 per share a year ago.

Related Symbols 1
BRLT BRLT
Source: Zacks Investment Research
Visit Source
0 0 0
Read More
Comment
Zacks Investment Research News Agency
4 days ago•Zacks Investment Research
Stocks Medium Importance Neutral
Blackstone Secured Lending Fund (BXSL) Surpasses Q2 Earnings Estimates

Blackstone Secured Lending Fund (BXSL) Surpasses Q2 Earnings Estimates

Blackstone Secured Lending Fund (BXSL) came out with quarterly earnings of $0.75 per share, beating the Zacks Consensus Estimate of $0.66 per share. This compares to earnings of $0.77 per share a year ago.

Related Symbols 1
BXSL BXSL
Source: Zacks Investment Research
Visit Source
0 0 0
Read More
Comment
Zacks Investment Research News Agency
4 days ago•Zacks Investment Research
Stocks Medium Importance Neutral
Constellation Energy Corporation (CEG) Q2 Earnings and Revenues Beat Estimates

Constellation Energy Corporation (CEG) Q2 Earnings and Revenues Beat Estimates

Constellation Energy Corporation (CEG) came out with quarterly earnings of $2.55 per share, beating the Zacks Consensus Estimate of $2.36 per share. This compares to earnings of $1.91 per share a year ago.

Related Symbols 1
CEG CEG
Source: Zacks Investment Research
Visit Source
0 0 0
Read More
Comment
Zacks Investment Research News Agency
4 days ago•Zacks Investment Research
Stocks Medium Importance Neutral
Americold Realty Trust Inc. (COLD) Q2 FFO and Revenues Surpass Estimates

Americold Realty Trust Inc. (COLD) Q2 FFO and Revenues Surpass Estimates

Americold Realty Trust Inc. (COLD) came out with quarterly funds from operations (FFO) of $0.35 per share, beating the Zacks Consensus Estimate of $0.32 per share. This compares to FFO of $0.36 per share a year ago.

Related Symbols 1
COLD COLD
Source: Zacks Investment Research
Visit Source
Special Offer LiteFinance Start Trading
0 0 0
Read More
Comment
Zacks Investment Research News Agency
4 days ago•Zacks Investment Research
Stocks Medium Importance Neutral
ConocoPhillips (COP) Tops Q2 Earnings and Revenue Estimates

ConocoPhillips (COP) Tops Q2 Earnings and Revenue Estimates

ConocoPhillips (COP) came out with quarterly earnings of $3.24 per share, beating the Zacks Consensus Estimate of $2.96 per share. This compares to earnings of $1.42 per share a year ago.

Related Symbols 1
COP COP
Source: Zacks Investment Research
Visit Source
0 0 0
Read More
Comment
Zacks Investment Research News Agency
4 days ago•Zacks Investment Research
Stocks Medium Importance Neutral
Cogent Communications (CCOI) Reports Q2 Loss, Misses Revenue Estimates

Cogent Communications (CCOI) Reports Q2 Loss, Misses Revenue Estimates

Cogent Communications (CCOI) came out with a quarterly loss of $0.8 per share versus the Zacks Consensus Estimate of a loss of $1.12. This compares to a loss of $1.21 per share a year ago.

Related Symbols 1
CCOI CCOI
Source: Zacks Investment Research
Visit Source
Special Offer LiteFinance Start Trading
0 0 0
Read More
Comment
24/7 Wall Street News Agency
4 days ago•24/7 Wall Street
Stocks Medium Importance Neutral
High Beta Runners Up: Why AMD and Marvell Technology Now Command Attention

High Beta Runners Up: Why AMD and Marvell Technology Now Command Attention

Advanced Micro Devices (NASDAQ:AMD | AMD Price Prediction) and Marvell Technology (NASDAQ:MRVL) have cleared their most recent earnings, deepening the case for treating them as the market's preferred high beta alternatives to NVIDIA (NASDAQ:NVDA) and Broadcom (NASDAQ:AVGO).

Related Symbols 1
AMD AMD
Source: 24/7 Wall Street
Visit Source
0 0 0
Read More
Comment
Seeking Alpha News Agency
4 days ago•Seeking Alpha
Stocks Medium Importance Neutral
ANI Pharmaceuticals: The Market Is Pricing The Present, Not The Future

ANI Pharmaceuticals: The Market Is Pricing The Present, Not The Future

ANI Pharmaceuticals is rated Buy at ~$80, with a 12-month fair value set at $95, as the current valuation undervalues 2027 earnings potential. 2026 results are depressed by upfront gout expansion costs and higher Corticotrophin royalties, but revenue and operating leverage from these investments are expected to materialize in 2027. Most 2026 Cortrophin growth is projected from established indications, not the new gout initiative, which is viewed as a 2027 upside driver.

Related Symbols 1
ANIP ANIP
Source: Seeking Alpha
Visit Source
0 0 0
Read More
Comment
GlobeNewsWire News Agency
4 days ago•GlobeNewsWire
Stocks Medium Importance Neutral
Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform

Silo Pharma Subsidiary QwikAgents Collaborates with Amazon Web Services Premier Tier Partner Caylent to Advance Enterprise AI Platform

Collaboration supports development of a next-generation AWS-native platform designed to accelerate commercialization, scalability and enterprise adoption

Related Symbols 1
PINC PINC
Source: GlobeNewsWire
Visit Source
Special Offer LiteFinance Start Trading
0 0 0
Read More
Comment
Newsfile Corp News Agency
4 days ago•Newsfile Corp
Stocks Medium Importance Neutral
ATERRA Metals Commences Preparation of Maiden Mineral Resource Estimate for the Totora Cu/Au Project

ATERRA Metals Commences Preparation of Maiden Mineral Resource Estimate for the Totora Cu/Au Project

Toronto, Ontario--(Newsfile Corp. - August 6, 2026) - ATERRA Metals Inc. (CSE: ATC) (OTCQB: CSSCF) ("ATERRA" or the "Company") is pleased to announce that it has commenced preparation of the Company's maiden independent Mineral Resource Estimate ("MRE") for its Totora Cu/Au Project ("Totora" or the "Project"). The maiden MRE will define Totora's initial mineral inventory and establish the technical foundation for future economic studies.

Related Symbols 1
MHLD MHLD
Source: Newsfile Corp
Visit Source
0 0 0
Read More
Comment
GlobeNewsWire News Agency
4 days ago•GlobeNewsWire
Stocks Medium Importance Neutral
Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call

Milestone Scientific Schedules Second Quarter 2026 Financial Results Conference Call

ROSELAND, N.J., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today announced that it will host a conference call at 8:30 AM Eastern Time on Friday, August 14, 2026, to discuss the company's financial results for the second quarter ended June 30, 2026, as well as the company's corporate progress and other developments.

Related Symbols 1
MLSS MLSS
Source: GlobeNewsWire
Visit Source
0 0 0
Read More
Comment